Medasense For Profit
Medasense is transforming the way PAIN is being assessed and treated worldwide. Through our breakthrough NOL® AI technology and sensing platform, we quantify pain response to optimize care and avoid overmedication.
Founded Date:
2008-01-01
Last Funding Type:
Series C
Headquarters:
Ramat Gan, Tel Aviv, Israel
Investors Number:
10
Technology:
Machine learning
Employee Number:
11-50
Industry:
AI for Longevity
Estimated Revenue:
$6.9 Million
Last Funding Date:
22.09.2020
Funding Status:
Late Stage Venture